Sequential use of biologics in moderate-to-severe plaque psoriasis: case studies illustrating an individualized approach-Reference-Cited by-同舟云学术

Sequential use of biologics in moderate-to-severe plaque psoriasis: case studies illustrating an individualized approach

Published:2012-10-22 Issue: Volume:167 Page:21-26
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Goodfield M.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2012.11210.x/fullpdf

Reference21 articles.

1. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data;Rustin;Br J Dermatol,2012

2. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis;Leman;Br J Dermatol,2012

3. Tumor necrosis factor and anti-tumor necrosis factor therapies;Keystone;J Rheumatol Suppl,2010

4. An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up;Reich;J Drugs Dermatol,2012

5. Etanercept provides a more physiological approach in the treatment of psoriasis;Altomare;Dermatol Ther,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns, adherence, and persistence among psoriasis patients treated with biologics in a real-world setting, overall and by disease severity;Journal of Dermatological Treatment;2018-07-23

2. Five-year experience with infliximab: Follow up of the product familiarisation program;Australasian Journal of Dermatology;2015-09-16

3. Cost-Effectiveness of Biologic Agents in the Treatment of Moderate-to-Severe Psoriasis: A Brazilian Public Health Service Perspective;Value in Health Regional Issues;2014-12